NCT00652717View on ClinicalTrials.gov

Study To Assess The Efficacy Of A Cholesterol Lowering Drug On Top Of Statins In Patients After Myocardial Infarction (MI)(0653A-150)

PHASE4CompletedINTERVENTIONAL

Enrollment

280

Participants

Timeline

Start Date

February 1, 2005

Primary Completion Date

February 15, 2005

Study Completion Date

August 4, 2005

Conditions

Cardiovascular Disorder

Interventions

DRUG

Ezetimibe

Ezetimibe 10 mg daily for 42 days.

DRUG

simvastatin

simvastatin (prescribed clinically suitable dose by the physician), for mean follow up of 42 days.

All Listed Sponsors

lead

Organon and Co

INDUSTRY

NCT00652717 - Study To Assess The Efficacy Of A Cholesterol Lowering Drug On Top Of Statins In Patients After Myocardial Infarction (MI)(0653A-150) | Biotech Hunter | Biotech Hunter